Weekly Industry News - Pharma & Healthcare | American Conference Institute

Pharma & Healthcare – this week’s update includes Coloplast’s $16 million lawsuit, FDA issues referrals letters and more.

Coloplast: $16 Million to Settle 400 Transvaginal Mesh Lawsuits by C. Calvin Warriner III Published on jdsupra

While it is not official, Bloomberg is reporting that Coloplast A/S, one of the smaller manufacturers of transvaginal meshes, is said to be willing to settle a number of lawsuits for $16 million… [ Read More ]

One Of Pharma’s Biggest Enemies Goes After The Future’s Best-Selling Drug by Mathew Herper Published on Forbes

Over the past two decades, U.S. Representative Henry Waxman has given the drug industry good reason to fear him. Waxman (D.-California) humiliated Merck in open hearings by publicizing sales training materials that indicated the company had instructed its reps to deliberately downplay the heart risks of the pain pill Vioxx — a game Merck literally called “Dodgeball.”… [ Read More ]

FDA Issuing Referral Letters To State Boards Of Pharmacy Against Traditional Pharmacies by Melissa Gilmore Published on jdsupra

FDA has recently issued several “referral letters” (RLs) to state boards of pharmacy based on year-old pre-Compounding Quality Act Form 483 Inspectional Observations. FDA counts RLs as new instruments of oversight designed to strengthen their power over both state boards of pharmacies and state-regulated pharmacies… [ Read More ]